Clinical trial experts turn to AI and new partnerships to tackle growing trial complexity
Next month, senior-level speakers from leading pharma companies such as Roche, AstraZeneca and Novartis, along with speakers from emerging biotechs…
Next month, senior-level speakers from leading pharma companies such as Roche, AstraZeneca and Novartis, along with speakers from emerging biotechs…
For decades, randomised controlled trials (RCTs) have been considered the gold standard of clinical research. But as healthcare data becomes…
In recent years, wearable devices that track sleep, activity, heart rate, and recovery through smartwatches, fitness bands, and rings have…
The upcoming Outsourcing in Clinical Trials UK & Ireland 2026 conference, taking place on 9–10 June 2026 in London, UK,…
The South Korean government’s ambition to become a top three global clinical trial hub by 2030 is reshaping how the…
In the context of the increasing prevalence of chronic diseases, the global radiopharmaceutical market is gaining momentum and is projected…
The UAE is quickly advancing its precision medicine and genomics capabilities, establishing itself as a major emerging global clinical trial…
The Asia-Pacific (APAC) clinical trial landscape is undergoing a shift, with clinical trial activity rising two to three times faster…
At the upcoming Outsourcing in Clinical Trials (OCT) and Clinical Trial Supply (CTS) Korea 2025 meetings, which will take place…
The biotech sector has faced a challenging first half of 2025, underperforming relative to the broader tech industry and the…